4/6
05:38 pm
tsha
Taysha Gene Therapies (TSHA) Making Progress on Crucial Rett Syndrome Treatment [Yahoo! Finance]
Low
Report
Taysha Gene Therapies (TSHA) Making Progress on Crucial Rett Syndrome Treatment [Yahoo! Finance]
4/6
11:25 am
tsha
Taysha Gene Therapies (TSHA) had its price target raised by Canaccord Genuity Group Inc. from $14.00 to $17.00. They now have a "buy" rating on the stock.
Low
Report
Taysha Gene Therapies (TSHA) had its price target raised by Canaccord Genuity Group Inc. from $14.00 to $17.00. They now have a "buy" rating on the stock.
4/3
08:00 am
tsha
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
3/30
06:20 am
tsha
Taysha Gene Therapies (TSHA) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
Low
Report
Taysha Gene Therapies (TSHA) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
3/26
05:49 am
tsha
Taysha Gene Therapies (TSHA) was upgraded by Truist Financial Corporation to "strong-buy".
Medium
Report
Taysha Gene Therapies (TSHA) was upgraded by Truist Financial Corporation to "strong-buy".
3/21
01:29 pm
tsha
How FDA Breakthrough Status For TSHA-102 At Taysha Gene Therapies (TSHA) Has Changed Its Investment Story [Yahoo! Finance]
Low
Report
How FDA Breakthrough Status For TSHA-102 At Taysha Gene Therapies (TSHA) Has Changed Its Investment Story [Yahoo! Finance]
3/21
01:31 am
tsha
Low
Report
3/20
08:05 am
tsha
Taysha Gene Therapies (TSHA) had its price target raised by Needham & Company LLC from $10.00 to $12.00. They now have a "buy" rating on the stock.
Low
Report
Taysha Gene Therapies (TSHA) had its price target raised by Needham & Company LLC from $10.00 to $12.00. They now have a "buy" rating on the stock.
3/20
06:58 am
tsha
Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/19
03:27 pm
tsha
Taysha Gene Therapies Inc (TSHA) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]
Low
Report
Taysha Gene Therapies Inc (TSHA) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]
3/19
02:52 pm
tsha
Taysha Gene Therapies (TSHA) had its "buy" rating reaffirmed by Chardan Capital. They now have a $12.00 price target on the stock.
Low
Report
Taysha Gene Therapies (TSHA) had its "buy" rating reaffirmed by Chardan Capital. They now have a $12.00 price target on the stock.
3/19
10:33 am
tsha
Taysha (TSHA) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Taysha (TSHA) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
3/19
08:05 am
tsha
Taysha Gene Therapies GAAP EPS of -$0.34 beats by $0.02, revenue of $9.77M beats by $3.47M [Seeking Alpha]
Low
Report
Taysha Gene Therapies GAAP EPS of -$0.34 beats by $0.02, revenue of $9.77M beats by $3.47M [Seeking Alpha]
3/19
08:00 am
tsha
Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update
Low
Report
Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update
3/12
08:00 am
tsha
Taysha Gene Therapies to Release Full-Year 2025 Financial Results and Host Conference Call and Webcast on March 19
Low
Report
Taysha Gene Therapies to Release Full-Year 2025 Financial Results and Host Conference Call and Webcast on March 19
3/6
08:00 am
tsha
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
3/3
10:05 am
tsha
Gene Therapy Market Competitive Landscape Report 2026: Comprehensive Insights About 180+ Companies and 200+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type [Yahoo! Finance]
Low
Report
Gene Therapy Market Competitive Landscape Report 2026: Comprehensive Insights About 180+ Companies and 200+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type [Yahoo! Finance]
3/3
08:03 am
tsha
Taysha Gene Therapies (TSHA) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $10.00 price target on the stock.
Low
Report
Taysha Gene Therapies (TSHA) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $10.00 price target on the stock.
2/6
08:00 am
tsha
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2/2
09:44 am
tsha
Taysha Gene Therapies, Inc. (TSHA) Gains Wells Fargo's Support on Rett Syndrome Program Progress [Yahoo! Finance]
Low
Report
Taysha Gene Therapies, Inc. (TSHA) Gains Wells Fargo's Support on Rett Syndrome Program Progress [Yahoo! Finance]
1/29
04:42 pm
tsha
Here's What Analysts Are Saying About Taysha Gene Therapies (TSHA) [Yahoo! Finance]
Low
Report
Here's What Analysts Are Saying About Taysha Gene Therapies (TSHA) [Yahoo! Finance]